Morgan Stanley upgrades RH to Overweight with $530 price target, citing positive inflection and long-term fundamentals.
Latest Ratings for RH
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Wells Fargo | Maintains | Overweight | |
| Jan 2022 | Citigroup | Maintains | Buy | |
| Sep 2021 | UBS | Maintains | Neutral |
